Sign inJoin waitlistJoin the waitlist

SD

Sally DeNardo

Internal Medicine

Credentials: · ·

History

Internal Medicine

Research

Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts
Cancer Research · 2002 · 190 citations
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma
Journal of Clinical Oncology · 1998 · 168 citations
Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent
Analytical Biochemistry · 1985 · Last of 5 authors · 156 citations

GD
Gerald DeNardo
212 papers
RO
Robert O'Donnell
47 papers
CR
Carol Richman
21 papers
AE
Alan Epstein
9 papers · 1 as a fellow
Kit Lam
8 papers
Frederick Meyers
7 papers
RW
Richard Wilder
4 papers
BL
Bryan Leigh
3 papers
EK
Elissa Kramer
3 papers
ET
Evan Tobin
3 papers
JG
Jeffrey Gregg
3 papers
John McGahan
3 papers

Grants

Targeting Agents for Human and Canine Lymphoma
National Cancer Institute · U19
Project lead · $1.4M · University of California at Davis
2005–2010
Translational Multimodality " Antibody" Therapy
National Cancer Institute · P01
Project lead · $2M · University of California at Davis
1988–2007
Clinical Trials of Biological Response Modifiers
National Cancer Institute · U01
Contact PI · $458.6K · University of California at Davis
1993–1997

Clinical trials

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
Study chair · Unknown · Phase 1
University of California, Davis
1996